Tian-lu K. Cheng
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.
Journal: International journal of biological macromolecules
Published: October 27, 2025
Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissue.
Journal: Journal of translational medicine
Published: September 14, 2025
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization.
Journal: NPJ vaccines
Published: May 28, 2025
Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy.
Journal: International journal of biological macromolecules
Published: February 17, 2025
Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacy.
Journal: Bioengineering & translational medicine
Published: October 14, 2024
Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].
Journal: International journal of biological macromolecules
Published: October 12, 2024
Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].
Journal: International journal of biological macromolecules
Published: September 20, 2024
Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancer.
Journal: International journal of biological macromolecules
Published: September 05, 2024
Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety.
Journal: International journal of biological macromolecules
Published: August 29, 2024
Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies.
Journal: ACS nano
Published: August 09, 2024
Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo.
Journal: Biomaterials research
Published: August 07, 2024
Last Updated: 09/26/2026